Literature DB >> 14651597

The effect of sildenafil on oesophageal motor function in healthy subjects and patients with nutcracker oesophagus.

J I Lee1, H Park, J H Kim, S I Lee, J L Conklin.   

Abstract

Type 5 phosphodiesterase terminates the action of nitric oxide (NO) induced 3',5'-cyclic monophosphate (cGMP). Sildenafil inhibits this phosphodiesterase, increases cellular cGMP concentrations and enhances NO-induced smooth muscle relaxation. We investigated the effect of sildenafil on the oesophageal motor function of healthy subjects and patients with nutcracker oesophagus. Eight healthy volunteers and nine patients with nutcracker oesophagus participated in this study. The participants underwent oesophageal manometries on two separate days after either 20 mL of distilled water or 0.8 mg kg-1 sildenafil dissolved in 20 mL of water was infused into the stomach. Lower oesophageal sphincter (LOS) resting pressure, the duration of LOS relaxation and the amplitudes of oesophageal pressure waves were examined before, and 7.5, 15, 30 and 60 min after either placebo or sildenafil. In both healthy subjects and patients with nutcracker oesophagus, sildenafil decreased resting LOS pressure and the amplitude of peristaltic pressure waves at 3, 8 and 13 cm above LOS. Sildenafil also prolonged the duration of LOS relaxation. It had no effect on the velocity of peristalsis or the amplitude of peristaltic pressure waves 18 cm above LOS. Sildenafil may be considered as an alternative treatment in nutcracker oesophagus although there are several limitations to be overcome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14651597     DOI: 10.1046/j.1350-1925.2003.00450.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  11 in total

Review 1.  Oesophageal motor functions and its disorders.

Authors:  R K Mittal; V Bhalla
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

2.  A questionnaire study to assess long-term outcome in patients with abnormal esophageal manometry.

Authors:  H L Spencer; L Smith; S A Riley
Journal:  Dysphagia       Date:  2006-07       Impact factor: 3.438

3.  Esophageal motility disorders (distal esophageal spasm, nutcracker esophagus, and hypertensive lower esophageal sphincter): modern management.

Authors:  Radu Tutuian; Donald O Castell
Journal:  Curr Treat Options Gastroenterol       Date:  2006-07

4.  Noncardiac chest pain: current treatment.

Authors:  Ron Schey; Autumn Villarreal; Ronnie Fass
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-04

Review 5.  Esophageal hypomotility and spastic motor disorders: current diagnosis and treatment.

Authors:  Miguel A Valdovinos; Monica R Zavala-Solares; Enrique Coss-Adame
Journal:  Curr Gastroenterol Rep       Date:  2014-11

6.  Inhibitory effects of sildenafil on small intestinal motility and myoelectrical activity in dogs.

Authors:  Xiaohong Xu; J D Z Chen
Journal:  Dig Dis Sci       Date:  2006-04       Impact factor: 3.199

Review 7.  The Relevance of Spastic Esophageal Disorders as a Diagnostic Category.

Authors:  Michelle P Clermont; Nitin K Ahuja
Journal:  Curr Gastroenterol Rep       Date:  2018-08-06

8.  Examination of the effects of vardenafil on esophageal function using multichannel intraluminal impedance and manometry.

Authors:  Tae Hee Lee; Joon Seong Lee; Su Jin Hong; Seong Ran Jeon; Wan Jung Kim; Hyun Gun Kim; Joo Young Cho; Jin-Oh Kim
Journal:  J Neurogastroenterol Motil       Date:  2012-10-09       Impact factor: 4.924

9.  High-Resolution Manometry in Clinical Practice.

Authors:  Dustin A Carlson; John E Pandolfino
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-06

10.  Two Distinct Types of Hypercontractile Esophagus: Classic and Spastic Jackhammer.

Authors:  Yun Soo Hong; Yang Won Min; Poong-Lyul Rhee
Journal:  Gut Liver       Date:  2016-09-15       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.